Plain-English translation of NCT05594927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called , given as a soft capsule, works better than tablet for treating advanced liver cancer that cannot be surgically removed. Both are herbal-derived treatments being studied as first-line options for patients with poor overall health conditions. The study will track how long patients live and how well they tolerate the medication.
Many patients with advanced liver cancer cannot have surgery or are not healthy enough for standard cancer treatments like immunotherapy or targeted drugs. This trial is testing whether this herbal medication could be a helpful option for these patients who have limited choices.
You would be randomly assigned to take either soft capsules or tablets as your first cancer treatment. You would continue taking the medication until it stops working or causes unacceptable side effects. The study will follow your health over time, measuring how long you survive and how well you tolerate the treatment. You will be one of 261 participants across multiple medical centers in this comparison study.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
China